Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V.: EHC announces change in CEO position | 1.376 | EQS Group (EN) | EQS-Ad-hoc: European Healthcare Acquisition & Growth Company B.V. / Key word(s): Personnel
European Healthcare Acquisition & Growth Company B.V. announces change in CEO position
02-May-2024... ► Artikel lesen | |
25.04. | EQS-News: European Healthcare Acquisition & Growth Company B.V. publishes its Annual Report 2023 | 237 | EQS Group (EN) | EQS-News: European Healthcare Acquisition & Growth Company B.V.
/ Key word(s): Annual Report
European Healthcare Acquisition & Growth Company B.V. publishes its Annual Report... ► Artikel lesen | |
15.11.23 | EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V.: General meeting of European Healthcare Acquisition & Growth Company B.V. adopts all resolutions, extending business combination deadline by up to one yea | 1.063 | EQS Group (EN) | EQS-Ad-hoc: European Healthcare Acquisition & Growth Company B.V. / Key word(s): AGM/EGM
General meeting of European Healthcare Acquisition & Growth Company B.V. adopts all resolutions... ► Artikel lesen | |
10.11.23 | EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V.: Expiry and delisting of the Warrants on 17 November 2023 | 1.377 | EQS Group (EN) | EQS-Ad-hoc: European Healthcare Acquisition & Growth Company B.V. / Key word(s): Miscellaneous
European Healthcare Acquisition & Growth Company B.V.: Expiry and delisting of the... ► Artikel lesen | |
07.11.23 | EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V.: Results of the Repurchase Offer | 1.010 | EQS Group (EN) | EQS-Ad-hoc: European Healthcare Acquisition & Growth Company B.V. / Key word(s): Miscellaneous
European Healthcare Acquisition & Growth Company B.V.: Results of the Repurchase... ► Artikel lesen | |
04.10.23 | EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V.: EHC convenes EGM to extend business combination deadline and publishes repurchase document relating to redemption of public shares and proposed amendment of Warrant T&C | 1.599 | EQS Group (EN) | EQS-Ad-hoc: European Healthcare Acquisition & Growth Company B.V. / Key word(s): ESG/Offer
EHC convenes EGM to extend business combination deadline and publishes repurchase document... ► Artikel lesen | |
27.09.23 | EQS-News: European Healthcare Acquisition & Growth Company B.V. publishes its half-year report 2023 | 393 | EQS Group (EN) | EQS-News: European Healthcare Acquisition & Growth Company B.V.
/ Key word(s): Half Year Report
European Healthcare Acquisition & Growth Company B.V. publishes its half-year... ► Artikel lesen | |
20.09.23 | EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V.: EHC announces intention to extend Business Combination Deadline, to offer redemption of Public Shares and to terminate all Public and Sponsor Warrants | 1.481 | EQS Group (EN) | EQS-Ad-hoc: European Healthcare Acquisition & Growth Company B.V. / Key word(s): Miscellaneous
European Healthcare Acquisition & Growth Company B.V. announces... ► Artikel lesen | |
24.08.23 | XFRA MISTRADE ANTRAG IN ISIN NL0015000K10 WURDE STATTGEGEBEN | 398 | Xetra Newsboard | Dem Mistrade-Antrag wurde stattgegeben. Folgende Geschaefte in der ISIN NL0015000K10, Wertpapier-Name: EHC B.V. CLASS A EO 1, wurden aufgehoben:Datum Zeit Volumen Preis24.08.2023 09:56:45 1,700 8.8 ► Artikel lesen | |
24.08.23 | XFRA MISTRADE ANTRAG IN ISIN NL0015000K10 WIRD GEPRUEFT | 338 | Xetra Newsboard | Fuer folgende Geschaefte in der ISIN NL0015000K10, Wertpapier-Name: EHC B.V. CLASS A EO 1, wird ein Mistrade-Antrag geprueft:Datum Zeit Volumen Preis24.08.2023 09:56:45 1,700 8.8Fair Value lt. Antragsteller:... ► Artikel lesen | |
07.08.23 | EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V.: EHC and Croma-Pharma GmbH terminate discussion on business combination | 2.798 | EQS Group (EN) | EQS-Ad-hoc: European Healthcare Acquisition & Growth Company B.V. / Key word(s): Miscellaneous
European Healthcare Acquisition & Growth Company B.V. and Croma-Pharma... ► Artikel lesen | |
27.06.23 | EQS-News: European Healthcare Acquisition & Growth Company B.V.: General meeting of shareholders of European Healthcare Acquisition & Growth Company B.V. adopts all resolutions | 550 | EQS Group (EN) | EQS-News: European Healthcare Acquisition & Growth Company B.V.
/ Key word(s): AGM/EGM
General meeting of shareholders of European Healthcare Acquisition & Growth Company... ► Artikel lesen | |
26.06.23 | EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V.: European Healthcare Acquisition & Growth Company removes shareholders' votes on proposed business combination with Croma-Pharma GmbH from agenda of general meeting | 1.578 | EQS Group (EN) | EQS-Ad-hoc: European Healthcare Acquisition & Growth Company B.V. / Key word(s): AGM/EGM
European Healthcare Acquisition & Growth Company B.V. removes shareholders'... ► Artikel lesen | |
23.06.23 | EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V.: European Healthcare Acquisition & Growth Company received redemption notices with respect to EUR 185.85 million - minimum net cash condition is not yet fulfilled | 2.202 | EQS Group (EN) | EQS-Ad-hoc: European Healthcare Acquisition & Growth Company B.V. / Key word(s): Miscellaneous
European Healthcare Acquisition & Growth Company B.V. received redemption... ► Artikel lesen | |
21.06.23 | EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V.: Public disclosure of inside information | 1.173 | EQS Group (EN) | EQS-Ad-hoc: European Healthcare Acquisition & Growth Company B.V. / Key word(s): Miscellaneous
European Healthcare Acquisition & Growth Company B.V.: Public disclosure of inside information
21-Jun-2023... ► Artikel lesen | |
16.05.23 | EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V.: EHC and Croma-Pharma GmbH, agree on adjusted enterprise value of Croma, and Sponsors waive 20% sponsor shares and devalue 20% sponsor warrants | 2.763 | EQS Group (EN) | EQS-Ad-hoc: European Healthcare Acquisition & Growth Company B.V. / Key word(s): Miscellaneous
European Healthcare Acquisition & Growth Company B.V. and Croma-Pharma GmbH, agree on adjusted enterprise... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
MEDIOS | 13,980 | +0,43 % | Medios: Ein vergessener Pharmawert? | Der Kurs der Aktie von Medios (WKN: A1MMCC) verläuft seit einem Jahr sehr volatil, aktuell liegt er bei 15,90 €. Ein Blick auf den Mehrjahreschart zeigt, dass seit dem Hoch gegen Ende 2021 ein Kursrückgang... ► Artikel lesen | |
PIRAEUS FINANCIAL | 3,806 | +0,40 % | PIRAEUS FINANCIAL HOLDINGS S.A.: Completion of sale of participation to a portfolio comprising mainly of non-performing exposures amounting to €0.4bn total legal claim with €0.16bn gross book value (Project Delta) (Correct Repetition) | ||
WUESTENROT & WUERTTEMBERGISCHE | 13,260 | +0,30 % | Klarer Sieger: Das wird aus 10.000 Euro Tagesgeld nach einem Jahr bei Postbank, comdirect, Wüstenrot | Es gibt einen klaren Sieger: 10.000 Euro als Tagesgeld bei Postbank, comdirect und Wüstenrot angelegt - so viel Geld ist nach einem Jahr auf dem Konto Die Zinsen beim Tagesgeld haben ihren Höhepunkt... ► Artikel lesen | |
T.ROWE PRICE | 103,72 | +0,14 % | T. Rowe Price: Advancing Leaders Through Innovation: Recognizing Asian American Native Hawaiian Pacific Islander Heritage Month | NORTHAMPTON, MA / ACCESSWIRE / May 2, 2024 / T. Rowe Price:As we recognize Asian American Native Hawaiian Pacific Island (AANHPI) Heritage Month, we celebrate the richness and dynamism of the Asian... ► Artikel lesen | |
GENERALI | 23,070 | +0,04 % | Änderungen im Vorstand von Generali und Cosmos | Die Generali Deutschland AG schafft ein neues Vorstandsressort und stellt den Vorstand der Cosmos Versicherungen neu auf: Katrin Gruber wird Chief Executive Officer und auch Nicole Heidemeyer und Petar... ► Artikel lesen | |
NAKIKI | 6,100 | +1,67 % | EQS-Adhoc: Nakiki SE: Geschäftsbericht der operativen Tochtergesellschaft; Optionsvolumen 133,4 Mio EUR | EQS-Ad-hoc: Nakiki SE / Schlagwort(e): Jahresbericht
Nakiki SE: Geschäftsbericht der operativen Tochtergesellschaft; Optionsvolumen 133,4 Mio EUR
22.04.2024 / 14:54 CET/CEST
Veröffentlichung... ► Artikel lesen | |
BANK OF CHINA | 0,418 | +0,55 % | Bank of China-Aktie gewinnt 3,15 Prozent (0,4255 €) | An der Börse notiert die Bank of China-Aktie gegenwärtig etwas fester. Der jüngste Kurs betrug 0,43 Euro. Für die Bank of China-Aktie steht gegenwärtig ein Wertanstieg 3,15 Prozent zu Buche. Die Aktie... ► Artikel lesen | |
LEGAL & GENERAL | 2,846 | +0,81 % | Legal & General Grp - Total Voting Rights | ||
NASDAQ | 56,78 | +0,37 % | NASDAQ, INC. - 8-K, Current Report | ||
ANNALY CAPITAL MANAGEMENT | 17,846 | -0,70 % | Annaly Capital Management's Total Return Won't Pay the Bills | ||
ALBIS LEASING | 2,180 | -4,39 % | EQS-AFR: ALBIS Leasing AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß § 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: ALBIS Leasing AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
ALBIS Leasing AG: Vorabbekanntmachung über... ► Artikel lesen | |
CHINA CONSTRUCTION BANK | 0,611 | -1,10 % | BOCI Slightly Cuts CCB TP to $8.21; Valuation Very Attractive | ||
MARKEL GROUP | 1.469,00 | 0,00 % | Markel Group reports 2024 first quarter results | RICHMOND, Va., May 1, 2024 /PRNewswire/ -- Markel Group Inc. (NYSE:MKL) today reported its financial results for the first quarter of 2024. The Company also announced today it filed its Form... ► Artikel lesen | |
ICICI BANK | 25,200 | -0,79 % | Bulk Deals: HDFC Mutual Fund buys 1.02% stake in Cyient; ICICI Mutual Fund purchases Total 4 Buyers shares | ||
BLUE OWL CAPITAL CORPORATION | 15,084 | +1,32 % | Blue Owl Capital Corporation Reports Full Year Results and Fourth Quarter Net Investment Income Per Share of $0.51 and NAV Per Share of $15.45; Increases Quarterly Dividend | NEW YORK, Feb. 21, 2024 /PRNewswire/ -- Blue Owl Capital Corporation (NYSE: OBDC, or the "Company") today announced financial results for its full year and fourth quarter ended December 31, 2023.
HIGHLIGHTS... ► Artikel lesen |